Page 3 - Precision Flow Plus News Today

Vapotherm, Inc. (NYSE:NYSE:VAPO) Q1 2022 Earnings Conference Call May 04, 2022, 16:30 ET Company Participants Mark Klausner - Westwicke Partners Joseph Army - CEO, President & Director...

Zacks Investment Research upgraded shares of Vapotherm (NYSE:VAPO – Get Rating) from a hold rating to a buy rating in a research report report published on Wednesday, Zacks.com reports. They currently have $5.25 price target on the stock. According to Zacks, “Vapotherm Inc. is a medical technology company. It designs and develops respiratory devices for […]

Vapotherm (NYSE:VAPO – Get Rating) is set to post its quarterly earnings results after the market closes on Wednesday, May 4th. Analysts expect the company to announce earnings of ($0.63) per share for the quarter. Vapotherm has set its FY 2022 guidance at EPS.Persons that are interested in participating in the company’s earnings conference call […]

A number of firms have modified their ratings and price targets on shares of Vapotherm (NYSE: VAPO) recently: 4/23/2022 – Vapotherm was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “Vapotherm Inc. is a medical technology company. It designs and develops respiratory devices for the […]

Vapotherm (NYSE:VAPO – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued to investors on Saturday, Zacks.com reports. According to Zacks, “Vapotherm Inc. is a medical technology company. It designs and develops respiratory devices for the treatment of chronic lung and acute breathing […]

Vapotherm (NYSE:VAPO – Get Rating) and USA Equities (OTCMKTS:USAQ – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, risk, earnings and institutional ownership. Profitability This table compares Vapotherm and USA Equities’ net margins, […]

Vapotherm (NYSE:VAPO – Get Rating) had its target price reduced by research analysts at Canaccord Genuity Group from $21.00 to $12.00 in a note issued to investors on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Canaccord Genuity Group’s price objective points to a potential upside of 82.37% from the […]

Vapotherm (NYSE:VAPO – Get Rating) had its target price cut by stock analysts at Canaccord Genuity Group from $21.00 to $12.00 in a research report issued on Wednesday, The Fly reports. Canaccord Genuity Group’s price objective indicates a potential upside of 92.93% from the company’s current price. VAPO has been the topic of a number […]

Canaccord Genuity has decided to maintain its Buy rating of Vapotherm (NYSE:VAPO) and lower its price target from $21.00 to $12.00. Shares of Vapo...

Vapotherm (NYSE:VAPO – Get Rating) was downgraded by equities researchers at Piper Sandler from an “overweight” rating to an “underweight” rating in a note issued to investors on Thursday, The Fly reports. A number of other equities research analysts also recently issued reports on VAPO. Canaccord Genuity Group reduced their price target on shares of […]